Avicatonin
Alternative Names: MCI 536Latest Information Update: 18 Dec 2003
At a glance
- Originator Mitsubishi Chemical
- Class Analgesics; Antihypercalcaemics; Osteoporosis therapies; Peptides
- Mechanism of Action Calcitonin stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation; Pain
- Discontinued Postmenopausal osteoporosis
Most Recent Events
- 18 Dec 2003 No development reported - Preclinical for Inflammation in Japan (IM)
- 18 Dec 2003 No development reported - Preclinical for Pain in Japan (IM)
- 09 Nov 1999 Preclinical development for Inflammation in Japan (IM)